CDKN2A and ovarian carcinoma: Indeed, the kit we used, SOPHiA HCS, is more focused on hereditary breast and ovarian cancer, Lynch syndrome and intestinal polyposis syndromes, that do not include CDKN2A among the most relevant genes.